Duloxetine for the long-term treatment of major depressive disorder in patients aged 65 and older: an open-label study.

Efficacy Mean changes from baseline for all efficacy outcomes were highly significant (p < .001, t-test for mean change) at all assessment times (Table 2 ).

also in 132,142 other papers